SEC Filings - Marker Therapeutics, Inc.

Filing date	Form	Description	View
Apr 6, 2022	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001104659-22-043219.pdf 0001104659-22-043219.rtf 0001104659-22-043219.xls View HTML
May 31, 2002	PRE 14C	A preliminary proxy statement containing all other information	0001000096-02-000342.pdf 0001000096-02-000342.rtf View HTML
Jan 17, 2014	PRE 14C	A preliminary proxy statement containing all other information	0001424884-14-000011.pdf 0001424884-14-000011.rtf 0001424884-14-000011.xls View HTML
Jan 6, 2010	PRE 14C	A preliminary proxy statement containing all other information	0001424884-10-000002.pdf 0001424884-10-000002.rtf 0001424884-10-000002.xls View HTML
Jul 13, 2018	PREM14A	A preliminary proxy statement relating to a merger or acquisition	0001144204-18-038363.pdf 0001144204-18-038363.rtf 0001144204-18-038363.xls View HTML
May 3, 2001	PRER14A	Proxy soliciting materials. Revised preliminary material	0001050502-01-500022.pdf 0001050502-01-500022.rtf View HTML
Sep 7, 2018	PRER14A	Proxy soliciting materials. Revised preliminary material	0001571049-18-000475.pdf 0001571049-18-000475.rtf 0001571049-18-000475.xls View HTML
Jun 5, 2002	PRER14C	Information statements. Revised preliminary material	0001050502-02-000434.pdf 0001050502-02-000434.rtf View HTML
Apr 27, 2001	PRES14A	A preliminary proxy statement giving notice regarding a special meeting	0001000096-01-500049.pdf 0001000096-01-500049.rtf View HTML
Aug 23, 2002	REGDEX	REGDEX	View HTML

Data provided by Kaleidoscope.